CD24 and nasopharyngeal carcinoma: In the present study, we evaluated the expression of CD24, CD44 and EpCAM in a set of NPC samples comprising of two cell lines (HK1 and C666-1) and two early-passage PDXs (xeno-284 and xeno-B110) by flow cytometry analysis.